Year |
Citation |
Score |
2022 |
Knelson EH, Ivanova EV, Tarannum M, Campisi M, Lizotte PH, Booker MA, Ozgenc I, Noureddine M, Meisenheimer B, Chen M, Piel B, Spicer N, Obua B, Messier CM, Shannon E, ... ... Abu-Yousif AO, et al. Activation of tumor-cell STING primes NK-cell therapy. Cancer Immunology Research. PMID 35678717 DOI: 10.1158/2326-6066.CIR-22-0017 |
0.335 |
|
2020 |
Khera E, Cilliers C, Smith MD, Ganno ML, Lai KC, Keating TA, Kopp A, Nessler I, Abu-Yousif AO, Thurber GM. Quantifying ADC bystander payload penetration with cellular resolution using pharmacodynamic mapping. Neoplasia (New York, N.Y.). 23: 210-221. PMID 33385970 DOI: 10.1016/j.neo.2020.12.001 |
0.323 |
|
2020 |
Abu-Yousif AO, Cvet D, Gallery M, Bannerman BM, Ganno ML, Smith MD, Lai KC, Keating TA, Stringer B, Kamali A, Eng K, Koseoglu S, Zhu A, Xia CQ, Saylor Landen M, et al. Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody-Drug Conjugate in Patient-Derived Xenografts. Molecular Cancer Therapeutics. PMID 32788205 DOI: 10.1158/1535-7163.MCT-19-1102 |
0.347 |
|
2019 |
Casaletto JB, Geddie ML, Abu-Yousif AO, Masson K, Fulgham A, Boudot A, Maiwald T, Kearns JD, Kohli N, Su S, Razlog M, Raue A, Kalra A, Håkansson M, Logan DT, et al. MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM. Proceedings of the National Academy of Sciences of the United States of America. PMID 30898885 DOI: 10.1073/Pnas.1819085116 |
0.305 |
|
2018 |
Gallery M, Zhang J, Bradley DP, Brauer P, Cvet D, Estevam J, Danaee H, Greenfield E, Li P, Manfredi M, Loke HK, Rabino C, Stringer B, Williamson M, Wyant T, ... ... Abu-Yousif A, et al. A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo. Plos One. 13: e0191046. PMID 29370189 DOI: 10.1371/journal.pone.0191046 |
0.351 |
|
2011 |
Evans CL, Abu-Yousif AO, Park YJ, Klein OJ, Celli JP, Rizvi I, Zheng X, Hasan T. Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT. Plos One. 6: e23434. PMID 21876751 DOI: 10.1371/Journal.Pone.0023434 |
0.332 |
|
Show low-probability matches. |